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Summary Fifty patients with operable breast carcinoma underwent fine needle aspiration for cytological
examination. The smears were prepared by means of the immunocytochemical method using monoclonal
antibodies for the determination of the oestrogen receptors (ER). After surgery the contents of the ER were
determined with the traditional biochemical technique. The results of the immunocytochemical method
showed 31 positives, two of which disagreed with the biochemical results, 15 negatives and four cases which
could not be assessed due to the absence of adequate numbers of cells. The ICA staining for ER was
expressed on a semiquantitative basis; there was a significant correlation between this and the values
expressed by the biochemical technique, with a coefficient of 0.83, P<0.000006.
Fine needle aspiration is one of the most reliable methods
for the diagnosis of carcinoma of the breast. In the hands of
experts, in fact, it proves to have extremely high sensitivity,
specificity, positive predictive value and negative predictive
value (Magdelenat et al., 1986). The technique offers several
advantages; it is atraumatic and does not require the use of
local anaesthesia; it can be repeated and is well-accepted by
patients, which means that it may be used in sequential
studies and for follow-up. Fine needle aspiration may be
performed on deep organs under echographic or
computerised tomographic control.
More recently, the material obtained by means of fine
needle aspiration has been used for the determination of
oestrogen receptors (ER) and progesterone receptors (PR) by
means of the traditional biochemical method (Benyahia et
al., 1982; Merle et al., 1985, 1986). Compared to the results
of determination performed on excised specimens, the
average accuracy of this technique is of 90%, but it is only
possible where the DNA concentration exceeds 20pmml-1
of cytosol, that is, when more than 1,000,000 cells are
present (Benyahia et al., 1982; Merle et al., 1985, 1986).
Furthermore, it does not offer any technical advantages
compared to the traditional method, since it needs the same
apparatus and cannot therefore be easily performed in small
hospitals or laboratories.
The production of monoclonal antibodies which are
specific for the receptors and the development of the
immunoperoxidase technique (Flowers et al., 1986; Green &
Jensen, 1982) have made it possible to analyse the ER
contents in cytological preparations containing a very small
number of cells.
We have used monoclonal antibodies for the
determination of the ER on smears from fine needle
aspirates obtained from breast carcinomas.
Materials and methods
From February 1987 until February 1988, 50 patients aged
from 29 to 74 years, with an average of 59.2, affected by
primary operable breast carcinoma, 20 at stageI and 30 at
stage II, underwent fine needle aspiration with cytological
examination and assessment of the ER contents. After
surgery, the ER and PR contents were examined on the
excised specimens by means of the traditional biochemical
method (Castagnetta et al., 1983; Clark & Peck, 1979; Leake
et al., 1979) (dextran-coated charcoal adsorption assay).
Four of the 50 cases could not be assessed because there
were no cells in the cytological smears.
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Immunocytochemical analysis
The cytological sampling was performed with 23 gauge
needles attached to 5 cm3 syringes, passed four or five times
in various directions in the neoplasia. The material thus
obtained was then smeared on to slides which had been
pretreated with a protenaceous solution containing an anti-
microbial substance. Two slides were prepared for each
patient, one with anti-ER antibodies and the other as a
control.
For fixation, the frozen slides were immersed in 3.6%
formol/phosphate buffered saline (PBS) at room temperature
for 15 min and then washed twice in PBS for a total of
10 min. They were then placed in absolute methanol
(-20°C) for 2 min, washed again in PBS at room
temperature for 5 min and stored in a cold (-20"C)
preparation of 250ml glycerol +42.8 g saccharose+0.33 g
chloride of magnesium with the addition of up to 500 ml of
PBS serum.
For the staining procedure we used the H222 Monoclonal
Antibody ER Assay Kit produced by Abbott
Laboratories, no. 3087-19, using one drop of solution per
slide.
Determination of the receptors
The traditional biochemical determination is expressed in
femtomol per milligram of cytosol. The immunocytochemical
determination was performed by means of the semi-
quantitative technique. The receptors are located inside the
nuclei and look brown if positive and light grey if negative.
The following parameters were taken into consideration:
intensity of staining, divided into (1) slightly, (2) moderately
and (3) intensely stained; percentage of epithelial cells with
positive receptors compared to the total number of epithelial
cells.
The receptor value is calculated by multiplying the
staining intensity by the percentage of positive epithelial
cells. The scale ranges from 0 to 300. The threshold value for
positivity for the biochemical method is 10 fmolmg - of
cytosol.
Data analysis
The validity of the immunocytochemical method was
assessed by calculating the sensitivity, the specificity, the
positive predictive value, the negative predictive value and
the accuracy. These are calculated as follows:
true positives (TP) sensitivity =true positives +false negatives (FN)
specificity - true negatives (TN)
true negatives +false positives (FP)
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positive predictive value =TP + FP
TN+F
negative predictive value = TN+FN
TP+TN
accuracy=TP+TN+FP+FN-
A comparison was made with the results obtained with the
semiquantitative and biochemical techniques by means of the
correlation coefficient and linear regression, with the values
expressed on a logarithmic scale.
Results
Of the 46 evaluable cases, the biochemical method showed
an ER concentration which was equal to or more than
10fmolmg-1 of cytosol in 29 cases, which were therefore
classified as positive. In 17 cases the ER concentration was
less than 10fmolmg-1 of cytosol and these were considered
as negative. Twenty-nine positive cases also gave a positive
result with the immunocytochemical method, while two of
the 17 negative cases also showed as positive with this
technique (Table I). One of these two positives concerned a
premenopausal patient; the other case was a post-
menopausal patient with 7.5 fmol mg 1 of cytosol ER and
1331.5fmolmg-1 of cytosolPR. The immunocytochemical
method showed 100% sensitivity, 88.2% specificity, 93.5%
positive predictive value, 100% negative predictive value and
95.6% accuracy.
Determination of ERs: the accuracy of the immunocyto-
logical method compared with the biochemical method in
determining ERs was: semiquantitative value >20; sensitivity
100%; specificity 88.2%; positive predictive value 93.5%;
negative predictive value 100%.
The correlation between the semiquantitative immuno-
cytochemical and quantitative biochemical methods,
calculated by means of linear regression, showed the
equation y = 0.27 + 0.78, P < 0.000006, and a correlation
coefficient of 0.83, P < 0.000006 (Figure 1).
Discussion
The determination of the hormone receptors plays an
extremely important role in the therapeutic management of
breast carcinoma since it can be used as a guide for the
treatment protocol of choice. ER positive tumours in fact
respond to hormone therapy in 60% of the cases, while ER
negative tumours show a response in less than 10%
(Osborne & McGuire, 1978).
The traditional method requires that the receptor assay be
made biochemically on excised specimens using the radio-
ligand technique. For this method, however, from 0.5 to 1 g
of tissue is necessary (Castagnetta et al., 1983) plus
sophisticated apparatus which may not always be available
in smaller hospitals.
Earlier diagnosis of carcinoma of the breast, together with
the larger number of investigations regarding the biology of
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Figure 1 Correlation of the logarithms of the ER values
between the biochemical (concentration of ERs expressed as
fmolmg- ) and. immunocytochemical (% positive ERICA
cells x staining intensity) methods.
the neoplasia, such as ER, cellular kinetics and DNA, now
mean that in some cases the quantity of tumoral tissue may
not be enough for histological diagnosis and biological
characterisation. Furthermore, patients with inoperable
tumours refuse to undergo surgery, and in those with distant
metastases of deep organs the tumoral tissue may be difficult
to get at.
Fine needle cytology is a not very invasive, cheap
technique, which is extremely useful for the sampling of a
number of tumoral cells sufficient for the biological
characterisation of the tumour, for example, by means of the
determination of the ER. With the traditional biochemical
method this latter requires a quantity of DNA of at least
20 ugml-1 of cytosol, that is, containing 1,000,000 cells
(Benyahia et al., 1982; Merle et al., 1985, 1986).
The advent of monoclonal antibodies has proved
extremely important for the determination of the ER in
several studies, most of which have been performed on tiny
slices of tumoral tissue by means of the enzyme-immuno-
assay technique. Compared to the classical biochemical
method, these studies have shown an average of 90%
sensibility, 82.3% specificity, 86.7% positive predictive value
(PPV) and 87.2% negative predictive value (NPV)
(Pertschuck et al., 1985; McCarty et al., 1985; King et al.,
1985; Shimada et al., 1985). Furthermore, the predictability
of the response to hormone therapy would seem to be higher
compared to the biochemical method (Pertschuck et al.,
1985; McCarty et al., 1985).
Enzyme-immunoassay with monoclonal antibodies has
also been assessed on fine needle aspirates. Magdelenat et al.
(1986) report that it is completely reliable, with a correlation
coefficient when the technique is performed on excised
specimens of 0.97. Moreover, it has a higher sensitivity than
the biochemical method performed on fine needle aspirates,
Table I Determination of ERs, comparison between immunocytological method on
fine needle aspirates and biochemical method on excised specimens
Authors Pos. value Neg. value False pos. False neg.
Crawford et al. (1985) 20 23 2 1
Flowers et al. (1986) 12 16 2 3
Azavedo et al. (1986) 20 8 3 0
Our results 29 15 2 0
Total 81 62 9 4
Sens. Spec. PPV NPV Acc.
95.2% 87.3% 91% 93.9% 91%
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and is possible on samples containing 10 lg of DNA per ml
of cytosol (Magdelenat et al., 1986).
The immunocytological technique with monoclonal anti-
bodies performed on fine needle aspirates offers the
advantage of being easier and more simple to perform and
of needing no special apparatus. It shows 90% accuracy,
92.8% sensitivity, 87.03% specificity, 88.1% PPV and 92.1%
NPV. Crawford et al. (1985) report 20 true positives, 22 true
negatives, two false positives and one false negative, while
Flowers et al. (1986) obtained 12 true positives, 16 true
negatives, two false positives and three false negatives, and
Azavedo et al. (1986) 20 true positives, eight true negatives,
three false positives and no false negatives (Table I).
In our own series we did not obtain any probably untrue
negatives, while one of the two discordant positives showed
an extremely high concentration of PR. The method also
offers a semiquantitative determination of the ER contents
with an acceptable correlation (Azavedo et al., 1986; Flowers
et al., 1986; Crawford et al., 1985), and we ourselves found a
significant correlation with a coefficient of 0.83. It has been
demonstrated that the ER contents may vary from one area
of the carcinoma to another; cell samples aspirated in
different directions within the tumour make it possible to
obtain a more complete picture of the receptor status of the
neoplasia. The material examined must contain a sufficient
quantity of tumoral tissue to make an accurate identification
of ER negative tumours, since the level of the receptors
depends on the cellularity of the carcinoma. A study
assessing the quantity of tumoral tissue reports that in 24%
of the ER negative cases there was a quantity of less than
10%, which is not sufficient for an accurate analysis (Steele
et al., 1987). The determination on smears prepared from
fine needle aspirates makes it possible to make a
simultaneous assessment of the cellular quantity.
At the present time the biochemical method is used when
the patient must undergo surgery; in cases of distant
metastases in deep organs, the immunocytochemical
technique may give excellent information regarding the ER
status, and may also be extremely efficient for studying the
sequential determination of the ER.
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